Objective: Wound infection remains a major source of postoperative morbidity leading to prolonged hospital stays and increased total cost, including indirect expenses related to the wound infection. We examined whether there is any higher risk of wound infection in patients undergo a reoperation after an initial operation or excision/incision biopsy. Methods and Results: A retrospective review of medical charts of patients with breast operations between January 1990 and July 2008 was carried out. The overall incidence of wound infection was 18.2% (231/ 1267). The rate of wound infection was (32%) when reoperation was done after previous modified radical mastectomy, 18.9% and 16.8% when the previous operations were lumpectomy/segmenectomy with axillary dissection and simple mastectomy without axillary dissection, respectively and (10.8%) when reoperation was performed after previous biopsy. Reoperation involving axillary dissection was associated with significantly higher rates of wound infection (p < 0.01). Antibiotic prophylaxis continued into the postoperative period was associated with significantly decreased rate of wound infection (p < 0.01). Conclusions: Initial procedure affects the risk of wound infection in subsequent operation in patients with breast cancer. Significantly higher risks of wound infection are seen in those patients who had undergone axillary dissection or modified radical mastectomy.
Introduction
Wound infection remains a major source of postoperative morbidity leading to prolonged hospital stays and increased total cost, including indirect expenses related to the wound infection. 1 Advances in surgical practice and antibiotic prophylaxis have not been successful in preventing the occurrence of wound infection although significant decreases in incidence have been reported. The average cost of a surgical wound infection has proven difficult to estimate and varies depending on the type of surgical procedure. 2 The entire economic burden of wound infections is rarely taken into account, as the majority of wound infections are not diagnosed until after hospital discharge 3, 4 ; the cost to the patient in prescription charges, visits to the hospital, loss of earnings, and reduced quality of life are largely underestimated. 2, 5, 15 In India, breast cancer is estimated to develop in approximately 230,000 women per year. 6 Keeping in view the recent trends, more women are opting for breast conservation therapy over mastectomy 7 ; thus with many women requiring one or more reexcisions to achieve negative margins. As the incidence of local recurrence has been shown to be increased with a concomitant decrease in overall survival when adjuvant therapy is delayed for more than 30 days; and wound infections after surgical therapy will delay adjuvant therapy, so prevention of postoperative wound infections takes on added importance. 7 Because breast surgery has been described as a clean operation, low wound infection rates have been reported, especially in populations treated with conservative techniques. 8, 9 The overall surgical site infection (SSI) rate following mastectomy reported to the Centers for Disease Control and Prevention National Nosocomial Infections Surveillance System from 1992 to 2004 was 1.98%. 10 Wound infection rates have been reported to be the lowest following breast-conserving surgery, ranging from 1.5% to 10.8%. [9] [10] [11] [12] Factors such as age, obesity, biopsy technique, neoadjuvant therapy, preoperative hospital stay, longer duration of operation, the use of drains, and breast reconstruction have all been suggested to explain the higher incidence of wound Infection after operation for breast cancer. 5, 7, 13, 14, [18] [19] [20] 
Material and methods
This study was conducted in the department of surgical oncology at Chittaranjan National Cancer Institute, Kolkata, India. After obtaining institutional review board approval, a retrospective review of medical charts of patients with breast operations between January 1990 and July 2008 was carried out. Only patients who had undergone more than one operation on breast were included in the study. Data were collected on patient demographics, the number of reoperations undergone by each patient, types of procedure, presence of co morbidities such as diabetes or immunosuppression, and antibiotics used for prophylaxis. The details of preoperative chemotherapy and/or radiotherapy were recorded for every patient.
Breast procedures included open biopsy (incisional or excisional), segmental mastectomy (lumpectomy), or mastectomy (total or modified radical) with or without immediate reconstruction. Wound infection was defined by means of Centers for Disease Control and Prevention 1999 guidelines [Infection occurs within 30 days after the operation if no implant is left in place or within 1 year if implant is in place and the infection appears to be related to the operation and infection involves deep soft tissues (e.g., fascial and muscle layers) of the incision]. The definitions entails at least one of the following criteria: (1) purulent drainage; (2) positive aseptically obtained culture; (3) periincisional erythema and incision opened by the surgeon; and (4) physician diagnosis of infection, which was predominantly a diagnosis of cellulitis for which antibiotics were prescribed. Dates of SSI were collected, with rates calculated for both a 30-day postoperative period and beyond. Findings of wound culture, if available, were recorded.v2 or Fisher's exact test was used to compare SSI rates for patients who did and did not receive postoperative antibiotic prophylaxis. Logistic regression was used to assess the effect of postoperative antibiotic prophylaxis while adjusting for potential confounding variables.
Results
Overall 1267 cases had undergone more than one operation. 882 (69%) of them had duct cell carcinoma not otherwise specified type, 37 (3%) had medullary type, 55 (4%) had colloid type and 5 (0.4%) had carcinosarcoma. DCIS was present in 200 (15.7%) and lobular carcinoma was in 88 (15.7%) Table 1 . Patients ranged in age from 15 to 79 years. The number of operations ranged from 2 to 6. Primary (first) operation was excisional/incisional biopsy in 111 (8.76%), lumpectomy/segmental mastectomy with or without axillary dissection in 894 (70.5%), total mastectomy in 225 (17.75%), and modified radical mastectomy in 37 (2.9%) patients. The average interval between initial intervention and the reoperation was 28.3 days (median of 10.2 days, range 5-425 days). The reoperative procedures were delayed in patients who had received chemotherapy or had presented with a locoregional recurrence after completion of surgical and adjuvant therapy. Types of reoperation undergone by the patients included mastectomy with or without axillary dissection, lumpectomy/segmental mastectomy with or without axillary dissection and mastectomy with reconstruction. Mastectomy was by far the commonest reoperation comprising 78.3% of procedures including cases with reconstruction ( Table 2) . Wound infection had occurred on 3-47 days after surgery (mean 10.5days). The patients were discharged on fifth to sixth postoperative day. None of the patients had required readmission to the hospital and were managed on outpatient basis. The overall incidence of wound infection was 18.2% (231/1267). The rate of wound infection was (32%) when previous operation was modified radical mastectomy, 18.9% and 16.8% when the previous operations were lumpectomy/segmenectomy with axillary dissection and simple mastectomy without axillary dissection, respectively and (10.8%) when reoperation was performed after previous biopsy. Reoperation involving axillary dissection was associated with higher rates of wound infection ( Table 2 ). When test of proportion was applied, the results were statistically significant (p < 0.05) in favour of modified radical mastectomy and lumpectomy/segmentectomy with axillary dissection in comparison with the initial operations of biopsy and simple mastectomy ( Table 2 ). 61 patients had diabetes mellitus; 34 (55.7%) developed wound infection.31 patients were on thyroxine replacement therapy for hypothyroidism; 1 (3%) patient developed wound infection. Other associated comorbidities like chronic obstructive pulmonary disease, mitral insufficiency, atrial fibrillation was present in 124 patients and 7 (5.6%) had wound infection. 989 (78%)patients had received both preoperative (single dose) and postoperative (mean 2.9, range 1-6 doses) antibiotic prophylaxis and 228 (23%) developed wound infection as compared with 278 (21.9%)patients who had received only post operative antibiotic prophylaxis (mean 4.57, range 4-6 doses) and wound infection developed in 103 (37%). Preoperative antibiotic prophylaxis continued into the postoperative period was associated with significantly decreased rate of wound infection (p < 0.01) Table 3 . However, it's hard to conclude whether the decreased rate of wound infection was affected in any measure by the post operative antibiotic usage or it was primarily the result of preoperative dose of antibiotics. 193 patients had positive wound cultures. Pseudomonas aeruginosa and staphylococcus were the commonest microorganisms, cultured in 26.4% and 24.3% cases, respectively. Staphylococcus epidermis and serratia sp. were documented in 16% cases each. MRSA were reported in 13.5%cases whereas the streptococcus was found in the least number of cases (3.6%) [ Table 4 ]. 575 patients (45.3%) had received chemotherapy average 21.6 days (range 18-78 days) before reoperation. 265 (20.9%) patients had completed chemotherapy and radiation treatment, with 215 (81%, n ¼ 265) having completed the adjuvant treatment more than 6 months before reoperation and 45 (16.9% n ¼ 265) having completed second line chemotherapy average 2.7 months before reoperative procedure. Drain placement was done in all patients. Drain removal was done on an average sixth day (range 4-11 days).
Discussion
The overall incidence of wound infection following reoperation in breast cancer was 18.2% in our study, which is significantly higher than the 1-3% infection rate expected for a 'clean' operation. The increased incidence of wound infection subsequent operations mirrors the infection rates following open biopsy, segmental mastectomy, and mastectomy. Tran CL et al. 12 have also reported a higher incidence of wound infection after reoperative breast surgery albeit lower (6.1%)than that of our study. However, they 12 have included a large number of cases who had undergone only core biopsy before the main operation. We did not include cases who had undergone core biopsy as an initial procedure because, as has been reported in the literature, core biopsy is associated with extremely low risk of wound infection in subsequent operations. 12 However there is only one published study which reports core biopsy as an independent risk factor for subsequent wound infection. 21 Some prior studies have considered the relationship between biopsy type and infection and Fine needle aspiration followed by mastectomy had the least risk of wound infection compared to two-step operations (i.e., biopsy with delayed mastectomy). 18, 19, 22 In addition, Rotstein et al. 19 noted that mastectomy had a higher incidence of wound infection when preceded by segmental mastectomy as opposed to excisional biopsy. Likewise, Lipshy et al. 20 found that mastectomies had lower infection rates when preceded by less invasive biopsy techniques, leading them to recommend fine needle aspiration or core biopsy. Tran Cl et al. 12 have also documented a higher post-operative wound infection rate after initial invasive procedures. The results of these studies are consistent with our finding that more invasive biopsy techniques and operative procedures resulted in a higher incidence of wound infection at reoperation. When the initial operation performed was modified radical mastectomy, the infection rate in subsequent reoperation was double the overall wound infection rate. When lumpectomy/segmentectomy with an axillary dissection, either lymph node sampling or complete lymph node clearance, was performed in the initial procedure, the incidence of wound infection was not only higher than that of the overall wound infection rate but it was significantly higher than the incidence in reoperation cases which had not undergone axillary dissection during initial operation (p < 0.05). This finding may be secondary to increased bacterial cross-contamination from the axilla, which is known to be heavily colonized with skin flora, and may also be a result of alterations in lymphatic flow following disruption of lymphatic channels in the axilla. 7, 17 Many studies have been reported that have assessed the efficacy of prophylactic antibiotics in operations for breast cancer.Ng D et al. 25 found in a nationwide survey, that, although antibiotic prophylaxis is not explicitly indicated for breast surgery, its use for these clean procedures is widely adopted, albeit to a different extent in different countries, often on the personal decision of the individual surgeon, but, currently, there is still no consensus regarding their use. 7, 18, 24 Platt et al. 16 found an approximately 40 per cent relative reduction in the incidence of wound infection after breast operation with the use of prophylactic antibiotics. Similarly, Esposito et al. 24 reported that antibiotic usage is more effective than placebo in preventing postoperative infections in breast surgery. Despite the lack of clear cut recommendations, prophylactic antibiotics are used routinely for many breast operations. Many surgeons will use prophylactic antibiotics for breast reoperations whether they do so or not for the initial breast operations. The rationale is that both the incision and wound cavity are seeded with skin bacteria by the first operation, and reoperation further increases the bacterial load, thereby increasing the risk of wound infection. Moreover, the serous fluid that forms in the wound cavity after initial operation can provide a nutrient-rich medium for bacterial proliferation. 12 We observed a statistically significant decrease in the postoperative wound infection rate [p < 0.01] in patients who had received antibiotics. Although the patients in our study had received pre-as well as postoperative antibiotics, we believe that preoperative dose of antibiotics has been, if at all, a decisive factor in causing a reduction of wound infection rate. The patients who received only post-operative antibiotic prophylaxis, on the contrary, had a significantly higher rate of wound infection. Throckmorton AD et al. 26 also, have reported in their randomized controlled study that post-operative antibiotic prophylaxis did not effect a reduction in the rate of wound infection. P. aeruginosa and Staphylococcus aureus were the commonest organisms causing wound infection in our study although serratia sp. And staphylococcus were also significantly important organisms albeit less common. MRSA were reported in only 13.5% cases only but majority of these were reported in patients who had undergone reoperation after the year 1999. We did not study the relationship of wound infection with preoperative chemotherapy or radiotherapy because we feel that this issue has been settled by a number of studies which have documented that chemotherapy and radiation do not lead to any increase in post operative wound infection. 27, 28 However, on the basis of this nonrandomized retrospective study of ours, it is hard to make definitive conclusions regarding the combined effect of reoperation and use of prophylactic antibiotics on the incidence of postoperative wound infections. However, based on our data, it appears that patients undergoing reoperative surgical procedures after previous incision/excision biopsy or mastectomy especially involving axillary dissection are a relatively high-risk group that may be more likely to benefit from methods to reduce the risk of developing postoperative wound infection.
Conclusions
The risk of wound infection in breast cancer is increased with reoperation.
This increase is most apparent when the initial procedure is a modified radical mastectomy or segmental mastectomy combined with lymph node dissection. Although risk of wound infection is lesser when initial procedures are incision/excision biopsy or mastectomy without axillary dissection, but it is still substantially higher than initial core biopsy or fine needle aspiration cytology followed by definitive operation. Although the use of prophylactic antibiotics for primary operation is still controversial, it seems to decrease the wound infection risk when used for reoperation. A prospective randomized, controlled trial comparing antibiotic versus placebo in patients undergoing reoperative breast surgery would be warranted to fully settle this question.
